RIOK2-IN-1

Modify Date: 2025-08-27 07:21:48

RIOK2-IN-1 Structure
RIOK2-IN-1 structure
Common Name RIOK2-IN-1
CAS Number 1088216-72-1 Molecular Weight 276.33
Density N/A Boiling Point N/A
Molecular Formula C18H16N2O Melting Point N/A
MSDS N/A Flash Point N/A

 Use of RIOK2-IN-1


RIOK2-IN-1 (com 4) is a potent and selective RIOK2 inhibitor (Kd=150 nM), but has low cellular activity (IC50=14,600 nM). RIOK2 is an atypical kinase associated with a variety of human cancers and is involved in ribosome maturation and cell cycle progression. The small molecule inhibitor CQ211 (HY-147655), an improvement of RIOK2-IN-1 as the lead compound, has good in vivo and in vitro activity, inhibits the proliferation of MKN-1 and HT-29 cancer cells, and can xenograft MKN in mice -1 model inhibits tumor progression[1].

 Names

Name RIOK2-IN-1

 RIOK2-IN-1 Biological Activity

Description RIOK2-IN-1 (com 4) is a potent and selective RIOK2 inhibitor (Kd=150 nM), but has low cellular activity (IC50=14,600 nM). RIOK2 is an atypical kinase associated with a variety of human cancers and is involved in ribosome maturation and cell cycle progression. The small molecule inhibitor CQ211 (HY-147655), an improvement of RIOK2-IN-1 as the lead compound, has good in vivo and in vitro activity, inhibits the proliferation of MKN-1 and HT-29 cancer cells, and can xenograft MKN in mice -1 model inhibits tumor progression[1].
Related Catalog
References

[1]. Ouyang Y, et al. Discovery of 8-(6-Methoxypyridin-3-yl)-1-(4-(piperazin-1-yl)-3-(trifluoromethyl)phenyl)-1,5-dihydro-4H-[1,2,3]triazolo[4,5-c]quinolin-4-one (CQ211) as a Highly Potent and Selective RIOK2 Inhibitor. J Med Chem. 2022 Jun 9;65(11):7833-7842.  

 Chemical & Physical Properties

Molecular Formula C18H16N2O
Molecular Weight 276.33
InChIKey HPQZTEVMVAVGJO-UHFFFAOYSA-N
SMILES Cc1ccnc(NC(=O)Cc2ccc3ccccc3c2)c1
The content on this webpage is sourced from various professional data sources. If you have any questions or concerns regarding the content, please feel free to contact service1@chemsrc.com.